News

Primary.Health Announces New Medical Director Aditya Chandrasekhar

Physician leader from Fenway Health in Boston joins the growing clinical team to fight ongoing health crisesBOSTON, Sept. 07, 2022…

2 years ago

22nd Century Group (Nasdaq: XXII) Launches VLN® Reduced Nicotine Content Cigarettes in Colorado with Circle K, Smoker Friendly and New Distribution Points

Two Additional Distribution Partnerships Will Target Thousands of Additional Colorado Retail StoresStrong Pilot Results Lead to Expanding VLN® Points of…

2 years ago

CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference

MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the…

2 years ago

Attralus Announces New Preclinical Data Demonstrating Novel Human Chimeric Antigen Receptor-Macrophages (CAR-M) for Potential Amyloid Removal at 18th International Symposium on Amyloidosis

Human CAR-M cells can be generated with the pan-amyloid reactive p5 peptide as the target amyloid recognition elementThis novel system…

2 years ago

Baptist Health’s Miami Cardiac & Vascular Institute successfully treats its first cardiac patients with new 3D Philips Intracardiac Echocardiography Catheter

Physician holding Philips real-time 3D intracardiac echocardiography catheter – VeriSight Pro – Philips real-time 3D intracardiac echocardiography catheter – VeriSight…

2 years ago

ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief…

2 years ago

Adial Pharmaceuticals Announces Positive In-Vivo Non-clinical Data with Purnovate’s PNV-6005 as a Potential Treatment for Ulcerative Colitis

PNV-6005 significantly reduced both weight loss and colon damage in ulcerative colitis animal model PNV-6005 - DSS-induced Ulcerative Colitis Model…

2 years ago

Iovance Biotherapeutics to Present Posters at ESMO 2022

SAN CARLOS, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel…

2 years ago

Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference

FARMINGTON HILLS, Mich., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused…

2 years ago

Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System

HINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Demonstrating another key achievement, Microbot Medical Inc. (Nasdaq: MBOT), continues to execute…

2 years ago